Cheryl McFarlane

807 citations
19 papers · 680 indexed · h-index 14

Cheryl McFarlane

19 papers receiving 672 citations

Peers

Cheryl McFarlane
Comparison fields: 5 of 80
  • Oncology 246
  • Immunology and Allergy 52
  • Cancer Research 128
  • Cell Biology 132
  • Molecular Biology 460
Replace Tushar B. Deb with:
Tushar B. Deb India
Murielle Glondu France
Kelsey Weigel United States
Rolando Pérez‐Lorenzo United States
Rajesh Patel United States
Dawo Liu China
Denis G. Bosc Canada
Thomas W. Owens United Kingdom
Antonio Candiloro Italy
Cheryl McFarlane relative to Tushar B. Deb India Tushar B. Deb's profile →
Citations per field
00.5×2.5×
Tushar B. Deb · 1×
Citations per year

Countries citing papers authored by Cheryl McFarlane

Since Specialization
Citations

This map shows the geographic impact of Cheryl McFarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl McFarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl McFarlane more than expected).

Fields of papers citing papers by Cheryl McFarlane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl McFarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl McFarlane. The network helps show where Cheryl McFarlane may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Cheryl McFarlane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cheryl McFarlane Line = papers co-authored together Cheryl McFarlane links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 20161
2 201588
3 201554
4 201417
5 201413
6 201344
7 201314
8 201339
9 201382
10 201152
11 201113
12 201087
13 201029
14 201030
15 201012
16 200970
17 20045
18 200319
19 199311

About Cheryl McFarlane

Cheryl McFarlane is a scholar working on Immunology and Allergy, Cell Biology and Oncology, having authored 19 papers that have together received 680 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (7 papers), Cell Adhesion Molecules Research (6 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Cell death mechanisms and regulation (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer Cells and Metastasis (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Proteoglycans and glycosaminoglycans research (2 papers). The work is most often cited by research in Oncology (246 citations), Immunology and Allergy (52 citations) and Cancer Research (128 citations). Cheryl McFarlane has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Christopher J. Scott, James F. Burrows, Michelle de la Vega, Ureshnie Govender, James A. Johnston, Alyson A. Kelvin, Suzanne McFarlane, James A. Johnston, A Hill and David Waugh. Their work appears in journals such as Oncotarget, Journal of Leukocyte Biology, Journal of Biological Chemistry, Cancer Research and Biochemical Society Transactions.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026